Identification of broad neutralizing antibodies against Omicron subvariants from COVID-19 convalescents and vaccine recipients

被引：1

作者：

Chen, Jun ^{[1
,3
]}

Yang, Jing ^{[2
]}

Chang, Fangfang ^{[4
]}

Hu, Yabin ^{[3
]}

Wu, Qian ^{[3
,4
]}

Teng, Shishan ^{[3
]}

Liu, Yongchen ^{[4
]}

Zhang, Jian ^{[3
]}

He, Rongzhang ^{[3
]}

Liu, Bo ^{[3
]}

Zheng, Xingyu ^{[3
]}

Liu, Ze ^{[5
]}

Peng, Yanxi ^{[6
]}

Xie, Zhenhua ^{[6
]}

Zhang, Yuanfang ^{[7
]}

Lu, Rui ^{[3
]}

Pan, Dong ^{[3
]}

Wang, You ^{[8
]}

Peng, Liting ^{[3
]}

Liu, Wenpei ^{[2
,3
]}

Li, Yi-Ping ^{[4
,9
]}

Qu, Xiaowang ^{[1
,3
]}

机构：

[1] Southern Med Univ, Sch Publ Hlth, Guangzhou 510515, Peoples R China

[2] Southern Med Univ, Sch Lab Med & Biotechnol, Guangzhou 510515, Peoples R China

[3] Univ South China, Peoples Hosp Chenzhou 1, Translat Med Inst, Hengyang Med Sch, Chenzhou 423000, Peoples R China

[4] Sun Yat sen Univ, Inst Human Virol, Zhongshan Sch Med, Dept Pathogen Biol & Biosecur, Guangzhou 510080, Peoples R China

[5] Xiangnan Univ, Sch Nursing, Chenzhou 423000, Peoples R China

[6] Xiangnan Univ, Coll Basic Med, Chenzhou 423000, Peoples R China

[7] Xiangnan Univ, Coll Pharm, Chenzhou 423000, Peoples R China

[8] Univ South China, Sch Publ Hlth, Hengyang Med Sch, Hengyang 421001, Peoples R China

[9] Sun Yat sen Univ, Affiliated Hosp 3, Dept Infect Dis, Guangzhou 510630, Peoples R China

来源：

VIROLOGICA SINICA | 2023年 / 38卷 / 02期

基金：

中国国家自然科学基金;

关键词：

D O I：

10.1016/j.virs.2023.01.005

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页码：313 / 316

页数：4

共 50 条

[1] Monovalent Omicron COVID-19 vaccine triggers superior neutralizing antibody responses against Omicron subvariants than Delta and Omicron bivalent vaccine
Li, Wanting
Zhao, Tiantian
Tao, Bai
Zhao, Liwei
Xiao, Hang
Ding, Xinyu
Li, Chuang
Chen, Lin
Cheng, Hao
Lou, Yang
Chen, Yuxin
Wu, Chao
[J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (02)
[2] Moving targets: COVID-19 vaccine efficacy against Omicron subvariants
da Silva, Maria Karolaynne
Fulco, Umberto Laino
da Silva Junior, Edilson Dantas
Nobre Oliveira, Jonas Ivan
[J]. MOLECULAR THERAPY, 2022, 30 (08) : 2644 - 2645
[3] Bivalent COVID-19 mRNA vaccine against omicron subvariants in immunocompromised patients
Solera, Javier T.
Ierullo, Matthew
Arbol, Berta G.
Mavandadnejad, Faranak
Kurtesi, Alexandra
Qi, Freda
Hu, Queenie
Gingras, Anne-Claude
Ferreira, Victor H.
Humar, Atul
Kumar, Deepali
[J]. LANCET INFECTIOUS DISEASES, 2023, 23 (08): : E266 - E267
[4] The Evolution of COVID-19: Omicron and Subvariants
Hammer, Mark M.
[J]. RADIOLOGY, 2023, 308 (01)
[5] Assessing COVID-19 vaccine effectiveness against Omicron subvariants: Report from a meeting of the World Health Organization
Feikin, Daniel R.
Higdon, Melissa M.
Andrews, Nick
Collie, Shirley
Knoll, Maria Deloria
Kwong, Jeffrey C.
Link-Gelles, Ruth
Pilishvili, Tamara
Patel, Minal K.
[J]. VACCINE, 2023, 41 (14) : 2329 - 2338
[6] Higher correlation between neutralizing antibodies and surrogate neutralizing or binding antibodies in COVID-19 patients than vaccine recipients
Lerdsamran, Hatairat
Anusorntanawat, Ratikorn
Sangsiriwut, Kantima
Sawadpongpan, Suteema
Prasertsopon, Jarunee
Thinpan, Nattakarn
Intalapaporn, Poj
Techasuwanna, Ranida
Okada, Pilailuk
Puthavathana, Pilaipan
[J]. PLOS ONE, 2024, 19 (04):
[7] Broadly neutralizing antibodies against COVID-19
Zhou, Daming
Ren, Jingshan
Fry, Elizabeth E.
Stuart, David, I
[J]. CURRENT OPINION IN VIROLOGY, 2023, 61
[8] Cilgavimab/tixagevimab unlikely to be active against some COVID-19 Omicron subvariants
[J]. Reactions Weekly, 2023, 1941 (1) : 1 - 1
[9] Omicron infection elicits a broad neutralizing response in hospitalized patients with COVID-19
McNally, Elizabeth M.
[J]. JOURNAL OF CLINICAL INVESTIGATION, 2022, 132 (23):
[10] Immunological strategies against spike protein: Neutralizing antibodies and vaccine development for COVID-19
Huang, Jiansheng
Huang, Hui
Wang, Dongdong
Wang, Chuan
Wang, Youfa
[J]. CLINICAL AND TRANSLATIONAL MEDICINE, 2020, 10 (06):

← 1 2 3 4 5 →